Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery (2023) Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DD, Fasching P, et al. Journal article Adjuvant radiotherapy and local recurrence in vulvar cancer – a subset analysis of the AGO-CaRE-1 study (2021) Woelber L, Prieske K, Eulenburg Cz, Corradini S, Petersen C, Bommert M, Blankenstein T, et al. Journal article Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer (2021) Konecny GE, Hendrickson AE, Davidson TM, Winterhoff BJ, Ma S, Mahner S, Sehouli J, et al. Journal article Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial (2021) Cibula D, Rob L, Mallmann P, Knapp P, Klat J, Chovanec J, Minar L, et al. Journal article Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study (2021) Prieske K, Woelber L, Muallem MZ, Eulenburg C, Jueckstock JK, Hilpert F, de Gregorio N, et al. Journal article Corrigendum to 'Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma' [Gynecologic Oncology 155 (2019) 499-507]. (2020) Zhou JG, Zhao HT, Jin SH, Tian X, Ma H Journal article, Erratum Concordance rate of vulvoscopic findings in detecting early vulvar neoplasia (2020) Stuebs FA, Mehlhorn G, Gaß P, Schulmeyer C, Adler W, Strehl J, Hartmann A, et al. Journal article Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study (2019) Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, et al. Journal article Genetic risk factors for ovarian cancer and their role for endometriosis risk (2017) Burghaus S, Fasching P, Haeberle L, Rübner M, Buechner K, Blum S, Engel A, et al. Journal article Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8) (2016) Emons G, Kurzeder C, Schmalfeldt B, Neuser P, De Gregorio N, Pfisterer J, Park-Simon TW, et al. Journal article